A.Giaccari1 · G. Gliozzo1 · G. Ciccarelli1 · G. Di Giuseppe1 · C. Castellano2 · S. Cum3 · L. Delle Monache4,13 · M. Gallo5 ·M.Lastretti6 · G. Medea7 · M. Monesi8 · R. Napoli9 · B. Pintaudi10 · E. Succurro11 · G. Turchetti
Received: 9 January 2026 / Accepted: 17 March 2026 © The Author(s) 2026
Abstract
Background and aims Although continuous glucose monitoring (CGM) devices are now standard of care among Type 1 diabetes patients, they are still relatively underutilized in Type 2 diabetes (T2D), particularly in those patients not treated with insulin. Widespread adoption continues to be hindered by a combination of factors. Chief among these is the scarcity of long-term, large-scale clinical trials demonstrating the benefits of the use of CGM in T2D. This meta-analysis aimed to address this gap by comparing CGM with self-blood glucose monitoring (SBMG), with primary outcomes of HbA1c and time in range (TIR) in insulin-treated and non-insulin-treated TD2 patients.
Methods and results Following the stringent rules mandated by our National Health Service (which requires a panel com-posed of all stakeholders involved in diabetes treatment, and includes PICO, GRADE, AGREE, and meta-analyses), we performed a systematic review of RCTs that enrolled two groups of individuals with T2D, those treated with insulin (includ-ing basal and basal-bolus regimens), and those receiving treatments other than insulin. All included trials compared CGM with structured blood glucose monitoring (SBGM) with glycated hemoglobin (HbA1c) as the main endpoint. Based on the strength and consistency of the evidence, the panel issued a strong recommendation in favor of CGM for individuals with T2D treated with insulin (including those on basal insulin alone) and for individuals with T2D not treated with insulin, par-ticularly for those with glycated hemoglobin levels≥7%. From a pharmacoeconomic perspective, outcomes were positive in both patient groups.
Conclusion CGM represents a clinically effective and cost-efficient approach to optimizing glycemic control in T2D, becom-ing mandatory among individuals on insulin therapy. Our findings support a shift in clinical practice toward the more widespread use of CGM in T2D, with regulatory frameworks and reimbursement policies needing to adapt accordingly.
Keywords CGM · Type 2 Diabetes · Metanalysis · PICO · GRADE · Guidelines
Communicated by Massimo Federici, M.D.
A. Giaccari 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
1 Center for Endocrine and Metabolic Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy
2 Azienda USL of Modena, Sassuolo Hospital, Sassuolo, Italy
3 Diabetes and Diabetic Foot Care Unit, ASUGI, Monfalcone, Italy
4 National Board Member of FAND (Italian Association for the Rights of Diabetic People), Roma, Italy
5 Department of Endocrinology and Metabolic Diseases, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
6 Order of Psychologists of Lazio, Rome, Italy
7 Italian Society of General Medicine (SIMG), Florence, Italy
8 Territorial Diabetology Unit, AUSL Ferrara, Ferrara, Italy
9 Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
10 Diabetes Unit, Niguarda Cà Granda Hospital, Milan, Italy
11 Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy
12 Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy
13 Patient Advocacy Lab, ALTEMS – Università Cattolica del Sacro Cuore, Rome, Italy
版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章。
引用本文:简喜超, 简扬, 邓呈亮. 2025版《中国糖尿病足防治实践指南》解读[J]. 中华医学美学美容杂志, 2026, 32(2): 99-103. DOI: 10.3760/cma.j.cn114657-20251215-00266.
通信作者:邓呈亮,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
AUTHORS
Sicco A. Bus1 , Larry A. Lavery2, Matilde Monteiro-Soares3 , Anne Rasmussen4, Anita Raspovic5 , Isabel C.N. Sacco6, Jaap J. van Netten1,7,8 on behalf of the International Working Group on the Diabetic Foot (IWGDF)
INSTITUTIONS
1 Amsterdam UMC, Department of Rehabilitation Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
2 Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
3 MEDCIDES: Departamento de Medicina da Comunidade Informação e Decisão em Saúde & CINTESIS – Center for Health Technology and Services Research, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
4 Steno Diabetes Center Copenhagen, Gentofte, Denmark
5 Discipline of Podiatry, School of Allied Health, Human Services and Sport, La Trobe University, Melbourne, Victoria, Australia
6 Physical Therapy, Speech and Occupational Therapy department, School of Medicine, University of São Paulo, São Paulo, Brazil
7 School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia
8 Diabetic foot clinic, Department of Surgery,Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands
KEYWORDS
diabetic foot; foot ulcer; guidelines; prevention; footwear; self-care; self-management; education www.iwgdfguidelines.org
Nicolaas C. Schaper1 , Jaap J. van Netten2,3,4, Jan Apelqvist5 , Sicco A. Bus2 , Robert J. Hinchlife6 , Benjamin A. Lipsky7 on behalf of the International Working Group on the Diabetic Foot (IWGDF)
1 Div. Endocrinology, MUMC+, CARIM and CAPHRI Institute, Maastricht, The Netherlands
2 Amsterdam UMC, Department of Rehabilitation Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
3 School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia
4 Diabetic foot clinic, Department of Surgery, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands
5 Department of Endocrinology, University Hospital of Malmö, Sweden
6 Bristol Centre for Surgical Research, University of Bristol, Bristol, UK
7 Department of Medicine, University of Washington, Seattle, USA; Green Templeton College, University of Oxford, Oxford, UK
diabetic foot; foot ulcer; guidelines; guidance; implementation; prevention; treatment www.iwgdfguidelines.org
Nithesh Naik 1,2, B. M. Zeeshan Hameed2,3 *, Sanjana Ganesh Nayak 4 , Anshita Gera4, Shreyas Raghavan Nandyal 5 , Dasharathraj K. Shetty 6 , Milap Shah2,7, Sufyan Ibrahim2,8 , Aniket Naik 8 , Nagaraj Kamath8 , Delaram Mahdaviamiri 9 , Kenisha Kevin D’costa10 , Bhavan Prasad Rai 2,11, Piotr Chlosta12 and Bhaskar K. Somani 2,13
1 Department of Mechanical and Manufacturing Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India,
2 iTRUE (International Training and Research in Uro-oncology and Endourology) Group, Manipal, India,
3 Department of Urology, Father Muller Medical College, Mangalore, India,
4 Department of Computer Science and Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India,
5 Gandhi Medical College, Kaloji Narayana Rao University of Health Sciences, Secunderabad, India,
6 Department of Humanities and Management, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India,
7 Robotics and Urooncology, Max Hospital and Max Institute of Cancer Care, New Delhi, India,
8 Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India,
9 Manipal College of Pharmaceutical Sciences, Manipal, Manipal Academy of Higher Education, Manipal, India,
10 Department of Biomedical Engineering, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India,
11 Department of Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom,
12 Department of Urology, Jagiellonian University in Krakow, Kraków, Poland,
13 Department of Urology,University Hospital Southampton NHS Trust, Southampton, United Kingdom
Telemedicine is the delivery of healthcare to patients who are not in the same location as the physician. The practice of telemedicine has a large number of advantages, including cost savings, low chances of nosocomial infection, and fewer hospital visits. Teleclinics have been reported to be successful in the post-surgery and post-cancer therapy follow-up, and in offering consulting services for urolithiasis patients. This review focuses on identifying the outcomes of the recent studies related to the usage of video consulting in urology centers for hematuria referrals and follow-up appointments for a variety of illnesses, including benign prostatic hyperplasia (BPH), kidney stone disease (KSD), and urinary tract infections (UTIs) and found that they are highly acceptable and satisfied. Certain medical disorders can cause embarrassment, social exclusion, and also poor self-esteem, all of which can negatively impair health-related quality-of-life. Telemedicine has proven beneficial in such patients and is a reliable, cost-effective patient-care tool, and it has been successfully implemented in various healthcare settings and specialties.
Keywords: telemedicine, telehealth, urology, patients perspective, COVID-19
Elizabeth A. Krupinski 1,* and Jordana Bernard 2
1 Department of Medical Imaging, University of Arizona, 1609 N Warren Bldg 211, Tucson,AZ 85724, USA
2 American Telemedicine Association, Washington, DC 20036, USA; E-Mail: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 * Author to whom correspondence should be addressed; E-Mail: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。;">该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。; Tel.: +1-520-626-4498; Fax: +1-520-626-4376.
Received: 10 December 2013; in revised form: 14 January 2014 / Accepted: 7 February 2014 /
Published: 12 February 2014
Abstract: The development of guidelines and standards for telemedicine is an important and valuable process to help insure effective and safe delivery of quality healthcare. Some organizations, such as the American Telemedicine Association (ATA), have made the development of standards and guidelines a priority. The practice guidelines developed so far have been well received by the telemedicine community and are being adopted in numerous practices, as well as being used in research to support the practice and growth of telemedicine. Studies that utilize published guidelines not only help bring them into greater public awareness, but they also provide evidence needed to validate existing guidelines and guide the revision of future versions. Telemedicine will continue to grow and be adopted by more healthcare practitioners and patients in a wide variety of forms not just in the traditional clinical environments, and practice guidelines will be a key factor in fostering this growth. Creation of guidelines is important to payers and regulators as well as increasingly they are adopting and integrating them into regulations and policies. This paper will review some of the recent ATA efforts in developing telemedicine practice guidelines, review the role of research in guidelines development, review data regarding their use, and discuss some of areas where guidelines are still needed.
Keywords: telemedicine; standards; guidelines; practice; research
Jennifer M. Polinski, ScD, MPH, Tobias Barker, MD, Nancy Gagliano, MD, Andrew Sussman, MD, Troyen A. Brennan, MD, JD, MPH, and William H. Shrank, MD, MSHS
CVS Health, Woonsocket, RI, USA.
BACKGROUND: One-quarter of U.S. patients do not have a primary care provider or do not have complete access to one. Work and personal responsibilities also compete with finding convenient, accessible care. Telehealth services facilitate patients’ access to care, but whether patients are satisfied with telehealth is unclear.
OBJECTIVE: We assessed patients’ satisfaction with and preference for telehealth visits in a telehealth program at CVS MinuteClinics.
DESIGN: Cross-sectional patient satisfaction survey.
PARTICIPANTS: Patients were aged ≥18 years, presented at a MinuteClinic offering telehealth in January–September 2014, had symptoms suitable for telehealth consultation, and agreed to a telehealth visit when the on-site practitioner was busy.
MAIN MEASURES: Patients reported their age, gender, and whether they had health insurance and/or a primary care provider. Patients rated their satisfaction with seeing diagnostic images, hearing and seeing the remote practitioner, the assisting on-site nurse’s capability, quality of care, convenience, and overall understanding. Patients ranked telehealth visits compared to traditional ones: better (defined as preferring telehealth), just as good (defined as liking telehealth), or worse. Predictors of preferring or liking telehealth were assessed via multivariate logistic
KEY RESULTS: In total, 1734 (54 %) of 3303 patients completed the survey: 70 % were women, and 41 % had no usual place of care. Between 94 and 99 % reported being Bvery satisfied^ with all telehealth attributes. Onethird preferred a telehealth visit to a traditional in-person visit. An additional 57 % liked telehealth. Lack of medical insurance increased the odds of preferring telehealth (OR=0.83, 95 % CI, 0.72–0.97). Predictors of liking telehealth were female gender (OR=1.68, 1.04–2.72) and being very satisfied with their overall understanding of telehealth (OR=2.76, 1.84–4.15), quality of care received (OR=2.34, 1.42–3.87), and telehealth’s convenience (OR=2.87, 1.09–7.94)
CONCLUSIONS: Patients reported high satisfaction with their telehealth experience. Convenience and perceived quality of care were important to patients, suggesting that telehealth may facilitate access to care.
KEY WORDS: telehealth; patient satisfaction; access to care.
Leslie A. Morland, PsyD,1 Michelle Raab, MA,1,2 Margaret-Anne Mackintosh, PhD,1,2 Craig S. Rosen, PhD,3,4 Clara E. Dismuke, PhD,5,6 Carolyn J. Greene, PhD,1,7 and B. Christopher Frueh, PhD8,9
1 Pacific Islands Division, National Center for PTSD, Department of Veterans Affairs Pacific Islands Healthcare System, Honolulu, Hawaii.
2 Pacific Health Research and Education Institute, Honolulu,
3 Dissemination and Training Division, National Center for PTSD, Department of Veterans Affairs Palo Alto Healthcare System, Palo Alto, California.
4 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.
5 Center for Disease Prevention and Health Interventions for Diverse Populations, Ralph H. Johnson VAMC, Department of Veterans Affairs, Charleston, South Carolina.
6 Center for Health Disparities Research, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
7 Center for Health Care Evaluation, Department of Veterans Affairs Palo Alto Healthcare System, Palo Alto, California.
8 The Menninger Clinic, Houston, Texas.
9 University of Hawaii, Hilo, Hawaii.
All views and opinions expressed herein are those of the authors and do not necessarily reflect those of the respective institutional affiliations or the Department of Veterans Affairs.
Background: Although effective psychotherapies for posttraumatic stress disorder (PTSD) exist, high percentages of Veterans in need of services are unable to access them. One particular challenge to providing cost-effective psychological treatments to Veterans with PTSD involves the difficulty and high cost of delivering in-person, specialized psychotherapy to Veterans residing in geographically remote locations. The delivery of these services via clinical video teleconferencing (CVT) has been presented as a potential solution to this access to care problem. Materials and Methods: This study is a retrospective cost analysis of a randomized controlled trial investigating telemedicine service delivery of an anger management therapy for Veterans with PTSD. The parent trial found that the CVT con dition provided clinical results that were comparable to the inperson condition. Several cost outcomes were calculated in order to investigate the clinical and cost outcomes associated with the CVT delivery modality relative to in-person delivery. Results: The CVT condition was significantly associated with lower total costs compared with the in-person delivery condition. The delivery of mental health services via CVT enables Veterans who would not normally receive these services access to empirically based treatments. Additional studies addressing long-term healthcare system costs, indirect cost factors at the patient and societal levels, and the use of CVT in other geographic regions of the United States are needed. Conclusions: The results of this study provide evidence that CVT is a costreducing mode of service delivery to Veterans with PTSD relative to in-person delivery.
Key words: medicine, military medicine, telehealth, telepsychiatry
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。